ClinicalTrials.Veeva

Menu

Obesity and Liver Function in Oesophageal Cancer

S

St. James's Hospital, Ireland

Status

Unknown

Conditions

Obesity
Liver Function

Treatments

Other: Observation of different types of obesity and liver pathology in patients undergoing and oesophagectomy

Study type

Observational

Funder types

Other

Identifiers

NCT04152044
SJH00003

Details and patient eligibility

About

There is an established link between sarcopenia and outcomes in oesophageal cancer. There is scant reports in the literature regarding the influences of different obesity in different compartments.

Full description

Oesophageal cancer rates are increasing as a result of obesity in Western society. Thr investigators are evaluating the influence of viscerala dn subcutaneous obesity on overall outcomes of the participants. In addition the investigators are evaluating if there is a correlation with Liver Function Tests and liver histopathology such as steatosis on survival in participants and post operative sequele.

Enrollment

658 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Those undergoing oesophagectomy

Exclusion criteria

  • patients who only had chemotherapy/chemoradiotherapy without surgery

Trial design

658 participants in 1 patient group

Liver biopsy, Visceral and subcutaneous obesity
Description:
Those with histology and LFT's and quantificaiton of obesity
Treatment:
Other: Observation of different types of obesity and liver pathology in patients undergoing and oesophagectomy

Trial contacts and locations

1

Loading...

Central trial contact

Noel E Donlon

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems